Ahmet Dirican
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer survivorship and care
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 44
- Colorectal Cancer Treatments and Studies 11
- Inflammatory Biomarkers in Disease Prognosis 9
- Cancer Diagnosis and Treatment 7
- Cancer Immunotherapy and Biomarkers 6
- Cancer survivorship and care 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- Mehmet KöseoğluAyşenur AtaySerap ÇuhadarYüksel KüçükzeybekÇiğdem ErtenLütfiye DemirAhmet Alacacıoğluİbrahim Vedat Bayoğlu
- Journals
- Biochemia Medica (2 papers)Journal of Sport Rehabilitation (2 papers)Clinical & Experimental Metastasis (2 papers)Medical Oncology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- TürkiyeUnited KingdomRussia
In The Last Decade
Ahmet Dirican
70 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Oncology 577
- Cancer Research 173
- Toxicology 36
- Pulmonary and Respiratory Medicine 262
- Complementary and alternative medicine 55
Countries citing papers authored by Ahmet Dirican
This map shows the geographic impact of Ahmet Dirican's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Dirican with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Dirican more than expected).
Fields of papers citing papers by Ahmet Dirican
This network shows the impact of papers produced by Ahmet Dirican. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Dirican. The network helps show where Ahmet Dirican may publish in the future.
Co-authors
The 25 scholars most cited alongside Ahmet Dirican, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 0 | |
| 3 | 2021 | 6 | |
| 4 | 2015 | 2 | |
| 5 | 2015 | 8 | |
| 6 | 2015 | 67 | |
| 7 | The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients. | 2014 | 6 |
| 8 | 2014 | 2 | |
| 9 | 2013 | 26 | |
| 10 | 2013 | 25 | |
| 11 | 2013 | 15 | |
| 12 | 2013 | 3 | |
| 13 | 2012 | 19 | |
| 14 | 2012 | 3 | |
| 15 | 2012 | 3 | |
| 16 | 2012 | 5 | |
| 17 | 2012 | 17 | |
| 18 | 2008 | 24 | |
| 19 | TANI TESTİ PERFORMANSLARININ DEĞERLENDİRİLMESİ VE KIYASLANMASI | 2001 | 2 |
| 20 | The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study. | 1996 | 13 |
About Ahmet Dirican
Ahmet Dirican is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Cancer Research and Internal Medicine, having authored 76 papers that have together received 1.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers), Cancer Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer survivorship and care (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Oncology (577 citations), Cancer Research (173 citations), Toxicology (36 citations), Pulmonary and Respiratory Medicine (262 citations) and Complementary and alternative medicine (55 citations). Ahmet Dirican has collaborated with scholars based in Türkiye, United Kingdom and Russia. Frequent co-authors include Mehmet Köseoğlu, Ayşenur Atay, Serap Çuhadar, Yüksel Küçükzeybek, Çiğdem Erten, Lütfiye Demir, Ahmet Alacacıoğlu, İbrahim Vedat Bayoğlu, Mustafa Oktay Tarhan and Murat Akyol. Their work appears in journals such as Biochemia Medica, Journal of Sport Rehabilitation, Clinical & Experimental Metastasis, Medical Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.